Tag archive for ‘NYSE MKT’
Jewish Business News On Tuesday, February 17th, 2015

Can-Fite Receives Notice of Allowance in US for Psoriasis Patent

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, announced that it has received a Notice of Allowance More...

Jewish Business News Service On Sunday, November 17th, 2013

Israeli Can-Fite BioPharma Announces Approval of ADR Listing on NYSE MKT

– The cancer and inflammatory drug development company will list its Level II ADRs on the NYSE MKT on Tuesday , November 19, 2013 under the ticker symbol “CANF”. – Israeli Can-Fite BioPharma More...

Wordpress site Developed by Fixing WordPress Problems